The Relevance of the Women’s Health Initiative Results on Combined Hormone Replacement Therapy in Clinical Practice

This publication has 34 references indexed in Scilit:

• Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
  JAMA, 2002
• Effect of hormone replacement therapy on insulin secretion and insulin sensitivity in postmenopausal diabetic women
  Gynecological Endocrinology, 2002
• Suppression of vasomotor and vulvovaginal symptoms with continuous oral 17β-estradiol
  Menopause, 2000
• Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer
  The Lancet, 1997
• Cause-Specific Mortality in Women Receiving Hormone Replacement Therapy
  Epidemiology, 1997
• Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolemia among postmenopausal women
  Journal of Internal Medicine, 1995
• The risk of acute myocardial infarction after oestrogen and oestrogen‐progestogen replacement
  BJOG: An International Journal of Obstetrics and Gynaecology, 1992
• Mortality in a cohort of long‐term users of hormone replacement therapy: an updated analysis
  BJOG: An International Journal of Obstetrics and Gynaecology, 1990
• Ischemic heart disease risk in postmenopausal women. Effects of estrogen use on glucose and insulin levels.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
• The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in women.
  Journal of Epidemiology and Community Health, 1989